BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23913681)

  • 1. Uric acid secretion from adipose tissue and its increase in obesity.
    Tsushima Y; Nishizawa H; Tochino Y; Nakatsuji H; Sekimoto R; Nagao H; Shirakura T; Kato K; Imaizumi K; Takahashi H; Tamura M; Maeda N; Funahashi T; Shimomura I
    J Biol Chem; 2013 Sep; 288(38):27138-27149. PubMed ID: 23913681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxanthine Secretion from Human Adipose Tissue and its Increase in Hypoxia.
    Nagao H; Nishizawa H; Tanaka Y; Fukata T; Mizushima T; Furuno M; Bamba T; Tsushima Y; Fujishima Y; Kita S; Funahashi T; Maeda N; Mori M; Fukusaki E; Shimomura I
    Obesity (Silver Spring); 2018 Jul; 26(7):1168-1178. PubMed ID: 29877616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome.
    Baldwin W; McRae S; Marek G; Wymer D; Pannu V; Baylis C; Johnson RJ; Sautin YY
    Diabetes; 2011 Apr; 60(4):1258-69. PubMed ID: 21346177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes.
    Murakami N; Ohtsubo T; Kansui Y; Goto K; Noguchi H; Haga Y; Nakabeppu Y; Matsumura K; Kitazono T
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):44-51. PubMed ID: 24158515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.
    Moriya C; Satoh H
    J Diabetes Res; 2016; 2016():3201534. PubMed ID: 27652270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
    Furuhashi M
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities.
    Harmon DB; Mandler WK; Sipula IJ; Dedousis N; Lewis SE; Eckels JT; Du J; Wang Y; Huckestein BR; Pagano PJ; Cifuentes-Pagano E; Homanics GE; Van't Erve TJ; Stefanovic-Racic M; Jurczak MJ; O'Doherty RM; Kelley EE
    Diabetes; 2019 Jun; 68(6):1221-1229. PubMed ID: 30936145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
    Wang H; Xie L; Song X; Wang J; Li X; Lin Z; Su T; Liang B; Huang D
    Front Immunol; 2022; 13():773001. PubMed ID: 35154100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
    Aibibula Z; Ailixiding M; Iwata M; Piao J; Hara Y; Okawa A; Asou Y
    Biochem Biophys Res Commun; 2016 Mar; 472(1):26-32. PubMed ID: 26903297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity.
    Cheung KJ; Tzameli I; Pissios P; Rovira I; Gavrilova O; Ohtsubo T; Chen Z; Finkel T; Flier JS; Friedman JM
    Cell Metab; 2007 Feb; 5(2):115-28. PubMed ID: 17276354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of hypoxanthine and xanthine by obesity in a general population.
    Furuhashi M; Koyama M; Higashiura Y; Murase T; Nakamura T; Matsumoto M; Sakai A; Ohnishi H; Tanaka M; Saitoh S; Moniwa N; Shimamoto K; Miura T
    J Diabetes Investig; 2020 Jul; 11(4):878-887. PubMed ID: 31916414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.
    Yasue S; Masuzaki H; Okada S; Ishii T; Kozuka C; Tanaka T; Fujikura J; Ebihara K; Hosoda K; Katsurada A; Ohashi N; Urushihara M; Kobori H; Morimoto N; Kawazoe T; Naitoh M; Okada M; Sakaue H; Suzuki S; Nakao K
    Am J Hypertens; 2010 Apr; 23(4):425-31. PubMed ID: 20057360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
    Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
    Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidoreductase and its inhibitors: relevance for gout.
    Day RO; Kamel B; Kannangara DR; Williams KM; Graham GG
    Clin Sci (Lond); 2016 Dec; 130(23):2167-2180. PubMed ID: 27798228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17A Differentially Induces Inflammatory and Metabolic Gene Expression in the Adipose Tissues of Lean and Obese Mice.
    Qu Y; Zhang Q; Ma S; Liu S; Chen Z; Mo Z; You Z
    Int J Mol Sci; 2016 Apr; 17(4):522. PubMed ID: 27070576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an anti-inflammatory toll-like receptor 9 (TLR 9) pathway in adipocytes.
    Thomalla M; Schmid A; Neumann E; Pfefferle PI; Müller-Ladner U; Schäffler A; Karrasch T
    J Endocrinol; 2019 Feb; 240(2):325-343. PubMed ID: 30508414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity.
    Inoue K; Maeda N; Mori T; Sekimoto R; Tsushima Y; Matsuda K; Yamaoka M; Suganami T; Nishizawa H; Ogawa Y; Funahashi T; Shimomura I
    PLoS One; 2014; 9(2):e87661. PubMed ID: 24516558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.